Loading
This expanded-access record concerns selpercatinib for cancers with activating RET changes. The registry now marks the program approved for marketing; this does not mean the former access program is recruiting.
This expanded-access record concerns selpercatinib for cancers with activating RET changes. The registry now marks the program approved for marketing; this does not mean the former access program is recruiting.
Expanded access study registered as NCT03906331, sponsored by Eli Lilly and Company. No drug-development phase applies in the structured registry record. Registry status checked October 10, 2026: approved for marketing. UCSF lists this study as closed to local enrollment; local availability and overall registry status are separate. See the registry for full eligibility and current sites.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-10. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares UCSF Helen Diller Family Comprehensive Cancer Center, Breast cancer (all types) and the tags ucsf-breast-coverage, expanded-access.
Shares UCSF Helen Diller Family Comprehensive Cancer Center, Breast cancer (all types) and the tag ucsf-breast-coverage.
Shares UCSF Helen Diller Family Comprehensive Cancer Center, Breast cancer (all types) and the tag ucsf-breast-coverage.
Shares UCSF Helen Diller Family Comprehensive Cancer Center, Breast cancer (all types) and the tag ucsf-breast-coverage.
Shares UCSF Helen Diller Family Comprehensive Cancer Center, Breast cancer (all types) and the tag ucsf-breast-coverage.
Shares UCSF Helen Diller Family Comprehensive Cancer Center, Breast cancer (all types) and the tag ucsf-breast-coverage.
Shares UCSF Helen Diller Family Comprehensive Cancer Center, Breast cancer (all types) and the tag ucsf-breast-coverage.
Shares UCSF Helen Diller Family Comprehensive Cancer Center, Breast cancer (all types) and the tag ucsf-breast-coverage.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/